Cargando…
Human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control
Strongyloides is a human parasitic nematode that is poorly understood outside a clinical context. This article identifies gaps within the literature, with particular emphasis on gaps that are hindering environmental control of Strongyloides. The prevalence and distribution of Strongyloides is unclea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337148/ https://www.ncbi.nlm.nih.gov/pubmed/32669892 http://dx.doi.org/10.2147/RRTM.S63138 |
_version_ | 1783554452688470016 |
---|---|
author | Taylor, Michael J Garrard, Tara A O’Donahoo, Francis J Ross, Kirstin E |
author_facet | Taylor, Michael J Garrard, Tara A O’Donahoo, Francis J Ross, Kirstin E |
author_sort | Taylor, Michael J |
collection | PubMed |
description | Strongyloides is a human parasitic nematode that is poorly understood outside a clinical context. This article identifies gaps within the literature, with particular emphasis on gaps that are hindering environmental control of Strongyloides. The prevalence and distribution of Strongyloides is unclear. An estimate of 100–370 million people infected worldwide has been proposed; however, inaccuracy of diagnosis, unreliability of prevalence mapping, and the fact that strongyloidiasis remains a neglected disease suggest that the higher figure of more than 300 million cases is likely to be a more accurate estimate. The complexity of Strongyloides life cycle means that laboratory cultures cannot be maintained outside of a host. This currently limits the range of laboratory-based research, which is vital to controlling Strongyloides through environmental alteration or treatment. Successful clinical treatment with antihelminthic drugs has meant that controlling Strongyloides through environmental control, rather than clinical intervention, has been largely overlooked. These control measures may encompass alteration of the soil environment through physical means, such as desiccation or removal of nutrients, or through chemical or biological agents. Repeated antihelminthic treatment of individuals with recurrent strongyloidiasis has not been observed to result in the selection of resistant strains; however, this has not been explicitly demonstrated, and relying on such assumptions in the long-term may prove to be shortsighted. It is ultimately naive to assume that continued administration of antihelminthics will be without any negative long-term effects. In Australia, strongyloidiasis primarily affects Indigenous communities, including communities from arid central Australia. This suggests that the range of Strongyloides extends beyond the reported tropical/subtropical boundary. Localized conditions that might result in this extended boundary include accumulation of moisture within housing because of malfunctioning health hardware inside and outside the house and the presence of dog fecal matter inside or outside housing areas. |
format | Online Article Text |
id | pubmed-7337148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-73371482020-07-14 Human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control Taylor, Michael J Garrard, Tara A O’Donahoo, Francis J Ross, Kirstin E Res Rep Trop Med Review Strongyloides is a human parasitic nematode that is poorly understood outside a clinical context. This article identifies gaps within the literature, with particular emphasis on gaps that are hindering environmental control of Strongyloides. The prevalence and distribution of Strongyloides is unclear. An estimate of 100–370 million people infected worldwide has been proposed; however, inaccuracy of diagnosis, unreliability of prevalence mapping, and the fact that strongyloidiasis remains a neglected disease suggest that the higher figure of more than 300 million cases is likely to be a more accurate estimate. The complexity of Strongyloides life cycle means that laboratory cultures cannot be maintained outside of a host. This currently limits the range of laboratory-based research, which is vital to controlling Strongyloides through environmental alteration or treatment. Successful clinical treatment with antihelminthic drugs has meant that controlling Strongyloides through environmental control, rather than clinical intervention, has been largely overlooked. These control measures may encompass alteration of the soil environment through physical means, such as desiccation or removal of nutrients, or through chemical or biological agents. Repeated antihelminthic treatment of individuals with recurrent strongyloidiasis has not been observed to result in the selection of resistant strains; however, this has not been explicitly demonstrated, and relying on such assumptions in the long-term may prove to be shortsighted. It is ultimately naive to assume that continued administration of antihelminthics will be without any negative long-term effects. In Australia, strongyloidiasis primarily affects Indigenous communities, including communities from arid central Australia. This suggests that the range of Strongyloides extends beyond the reported tropical/subtropical boundary. Localized conditions that might result in this extended boundary include accumulation of moisture within housing because of malfunctioning health hardware inside and outside the house and the presence of dog fecal matter inside or outside housing areas. Dove 2014-08-20 /pmc/articles/PMC7337148/ /pubmed/32669892 http://dx.doi.org/10.2147/RRTM.S63138 Text en © 2014 Taylor et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php |
spellingShingle | Review Taylor, Michael J Garrard, Tara A O’Donahoo, Francis J Ross, Kirstin E Human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control |
title | Human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control |
title_full | Human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control |
title_fullStr | Human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control |
title_full_unstemmed | Human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control |
title_short | Human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control |
title_sort | human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337148/ https://www.ncbi.nlm.nih.gov/pubmed/32669892 http://dx.doi.org/10.2147/RRTM.S63138 |
work_keys_str_mv | AT taylormichaelj humanstrongyloidiasisidentifyingknowledgegapswithemphasisonenvironmentalcontrol AT garrardtaraa humanstrongyloidiasisidentifyingknowledgegapswithemphasisonenvironmentalcontrol AT odonahoofrancisj humanstrongyloidiasisidentifyingknowledgegapswithemphasisonenvironmentalcontrol AT rosskirstine humanstrongyloidiasisidentifyingknowledgegapswithemphasisonenvironmentalcontrol |